Send Inquiry

Request To Call Back

Bevacizumab Injection 400 Mg

Get a Price/Quote

MOQ : 50 Vials

Bevacizumab Injection 400 Mg Specification

Indication
For use in metastatic or recurrent cancer treatment as indicated

Pacakaging (Quantity Per Box)
Usually 1 vial per box

Dosage Form
Parenteral

Salt Composition
Bevacizumab 400 mg

Life Span
18-24 months (see manufacturers expiry)

Origin of Medicine
Imported or Indian manufacture (varies)

Brand Name
Bevacizumab (varies by manufacturer, e.g., Avastin, Bevacirel, Bryxta, etc.)

Packaging Type
Vial

Drug Type
Prescription only, biological product

Ingredients
Bevacizumab

Physical Form
Injection

Function
Anti-cancer (anti-angiogenic agent)

Recommended For
Cancer treatment, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and others as prescribed

Dosage
400 mg per vial

Dosage Guidelines
As directed by the oncologist or prescribing physician

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze. Protect from light.

Contraindications
Hypersensitivity to Bevacizumab or excipients, pregnancy, certain cardiovascular conditions

Therapeutic Class
Antineoplastic agents - monoclonal antibodies

Prescription Status
Rx only

Adverse Effects
Hypertension, bleeding, proteinuria, impaired wound healing, gastrointestinal perforations, thromboembolism

Appearance
Clear to slightly opalescent, colorless to pale brown solution

Dilution Instructions
Must be diluted with 0.9% sodium chloride solution before use

Caution
Use with caution in patients with history of cardiovascular disease

Preservative Free
Yes

Mechanism of Action
Monoclonal antibody that inhibits VEGF (Vascular Endothelial Growth Factor), preventing angiogenesis

Shelf Life After Opening
Use immediately after dilution. If not, store diluted solution for up to 24 hours at 2C - 8C.

Regulatory Status
US FDA and DCGI approved (product-specific)

Clinical Use
Administered under medical supervision in hospital or clinical setting

Reconstitution Required
No, but requires dilution before administration

Administration Route
Intravenous infusion, diluted prior to administration

Bevacizumab Injection 400 Mg Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Vials Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Bevacizumab Injection 400 Mg

Discover the new, cost-effective Bevacizumab Injection 400 Mg, a crackerjack solution for advanced cancer care. This formidable, opulent monoclonal antibody works by inhibiting VEGF, preventing angiogenesis and tumor growth. Customizable dosing ensures tailored therapy per oncologist's direction. Each preservative-free vial contains a clear to pale brown solution, requiring no reconstitution but mandatory dilution before IV infusion. Approved by US FDA and DCGI, it is suitable for various cancers, including metastatic colorectal and non-small cell lung cancer. Storage and administration guidelines ensure optimal efficacy and safety.

Unlock Powerful Cancer Care: Usage & Competitive Edge

Bevacizumab Injection 400 Mg is indicated for the management of metastatic or recurrent cancers, including colorectal, lung, and brain tumors. Its anti-angiogenic mechanism curtails tumor blood supply with precision. Usage requires dilution in saline and intravenous infusion by healthcare professionals. Competitive advantages include proven clinical efficacy, customizable regimens, and approval by major health authorities. This solution is a formidable addition to the therapeutic arsenal, delivering reliable outcomes, enhanced safety, and exceptional adaptability for adult cancer patients.

Sample Policy, Certifications & Export Markets

Estimate sample dispatch and goods transport timelines by contacting our support team. Samples of Bevacizumab Injection 400 Mg are provided under strict clinical guidelines. The product holds recognized certifications, including US FDA and DCGI approval. Our main export markets encompass Asia, Africa, the Middle East, and other regions seeking advanced oncology solutions. Rely on us for timely exports and compliant documentation, ensuring your procurement process for this opulent monoclonal antibody meets global standards.

FAQ's of Bevacizumab Injection 400 Mg:

Q: How should Bevacizumab Injection 400 Mg be administered?

A: Bevacizumab Injection should be administered as an intravenous infusion after diluting it with 0.9% sodium chloride solution, under the supervision of a qualified healthcare professional.

Q: What are the recommended storage conditions for this product?

A: The injection should be stored in a refrigerator at 2C to 8C, protected from light, and should not be frozen. Use the diluted solution within 24 hours if stored at 2C to 8C.

Q: When is Bevacizumab Injection indicated for use?

A: It is recommended for treatment of metastatic or recurrent cancers including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and other types as prescribed by an oncologist.

Q: Where can this injection be administered?

A: Bevacizumab Injection is administered under strict medical supervision, usually in a hospital or clinical setting with appropriate monitoring.

Q: What are the main benefits of Bevacizumab Injection 400 Mg?

A: Main advantages include a formidable, targeted anti-cancer action, customizable dosing, and regulatory approval for multiple cancer indications, making it suitable for a variety of adult patients.

Q: How is the product packaged and supplied?

A: Each vial contains 400 mg of Bevacizumab and is supplied as a single vial per box, usually imported or manufactured in India, depending on brand availability.

Tell us about your requirement